Key result
Pleconaril is a broad-spectrum antipicornaviral agent that has demonstrated efficacy in reducing the duration and intensity of symptoms in enteroviral and rhinoviral infections.
Why the study?
Does pleconaril improve symptoms in patients with enteroviral and rhinoviral infections?
Population
Children and adults with enteroviral meningitis, adults with rhinoviral respiratory tract infections…
Design
Review
Authors
Loading...
Hypothesis-generating for pleconaril; leaves open clinical adoption pending randomized trials.
Does pleconaril improve symptoms in patients with enteroviral and rhinoviral infections?
Pleconaril is a promising broad-spectrum antipicornaviral agent that reduces symptom duration and intensity in enteroviral and rhinoviral infections.
José R. Romero (2001) conducted a review in Enteroviral and rhinoviral infections. Pleconaril was evaluated. Pleconaril is a broad-spectrum antipicornaviral agent that has demonstrated efficacy in reducing the duration and intensity of symptoms in enteroviral and rhinoviral infections.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: